IntrinsicIntrinsic
← Scroll for more →

Cerus Corp (CERS)

Surgical & Medical Instruments & Apparatus

Latest Price
$2.28
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.35
P/B Ratio
6.52

Valuation metrics

adjust assumptions →
Base FCF: $5M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$0.21
91% downside

Institutional Ownership

71.3% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
BlackRock, Inc.22.22M$64.0M11.08%+639.7K2026-06-30
ARK Investment Management LLC17.93M$52.0M8.94%-1.23M2026-06-30
Vanguard Capital Management LLC8.56M$25.0M4.27%+431.6K2026-06-30
Baker Bros. Advisors LP6.40M$18.0M3.19%-3.61M2026-06-30
D. E. Shaw & Co., Inc.5.49M$16.0M2.74%+1.75M2026-06-30
Geode Capital Management, LLC5.12M$14.0M2.55%+481.6K2026-06-30
State Street Corp4.75M$13.0M2.37%+539.1K2026-06-30
Senvest Management, LLC4.61M$13.0M2.30%+500.0K2026-06-30
Sumitomo Mitsui Trust Group, Inc.4.14M$12.0M2.06%-377.1K2026-06-30
Silvercrest Asset Management Group LLC4.08M$11.0M2.03%-164.2K2026-06-30
View all institutional holders →